Descartes-08
Phase 2Recruiting 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Antisynthetase Syndrome
Conditions
Antisynthetase Syndrome
Trial Timeline
Mar 1, 2026 → May 1, 2027
NCT ID
NCT07391605About Descartes-08
Descartes-08 is a phase 2 stage product being developed by Cartesian Therapeutics for Antisynthetase Syndrome. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07391605. Target conditions include Antisynthetase Syndrome.
Hype Score Breakdown
Clinical
12
Activity
15
Company
5
Novelty
0
Community
0
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07391605 | Phase 2 | Recruiting |
| NCT07089121 | Phase 1/2 | Recruiting |
| NCT06038474 | Phase 2 | Active |
| NCT04146051 | Phase 2 | Active |